The International TSC Clinical Consensus Group has recommended that independent genetic identification of pathogenic variants of the TSC1 or TSC2 gene should be sufficient to diagnose tuberous sclerosis disease regardless of clinical data. The gene discussed is TSC1; the disease is tuberous sclerosis.